MBII
Marrone Bio Innovations, Inc.
MBII
MBII
Delisted
MBII was delisted on the 12th of July, 2022.
62 hedge funds and large institutions have $45M invested in Marrone Bio Innovations, Inc. in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 22 closing their positions.
Holders
62
Holders Change
-9
Holders Change %
-12.68%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
12
Reduced
18
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GLAM
1
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
$2.32M |
| 2 |
2
Millennium Management
New York
|
$1.43M |
| 3 |
OFA
3
Oak Family Advisors
Chicago,
Illinois
|
$1.04M |
| 4 |
E
4
Ergoteles
New York
|
$1.58M |
| 5 |
EFI
5
EHP Funds Inc
Toronto,
Canada
|
$1.11M |
Top Sellers
| 1 |
1
BlackRock
New York
|
$615K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$1K |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$1.1M |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$225K |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$4.65M |
